Share on StockTwits

Sophiris Bio (NASDAQ:SPHS) Director James L. Heppell sold 19,231 shares of the company’s stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $2.59, for a total value of $49,808.29. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Shares of Sophiris Bio (NASDAQ:SPHS) traded up 4.17% on Monday, hitting $2.50. The stock had a trading volume of 30,302 shares. Sophiris Bio has a 52-week low of $2.25 and a 52-week high of $17.68. The stock’s 50-day moving average is $3.11 and its 200-day moving average is $3.65. The company’s market cap is $40.4 million.

Sophiris Bio (NASDAQ:SPHS) last released its earnings data on Tuesday, May 13th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.50) by $0.02. Analysts expect that Sophiris Bio will post $-1.65 EPS for the current fiscal year.

Separately, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of Sophiris Bio in a research note on Wednesday, May 14th. They now have a $7.00 price target on the stock, down previously from $9.00.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.